$INSY Insys Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Insys Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Insys Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Insys Therapeutics, Inc. for free.
IRS Number: 510327886
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: INSY
Company Address: 10220 SOUTH 51ST STREET SUITE 2 PHOENIX 85044
Phone number: 602-910-2617
Market Capitalization: $694.73M
Prev close: $9.96
Average Daily Volume: 950,029
Days Low: $9.63
Year Low: $8.70
Year High: $21.22
Insys Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 06 2019 | INSY | Insys Therapeutics ... | Housley Andrece | Chief Financial Off ... | Option Exercise | A | 4.30 | 31,008 | 133,334 | 31,008 | |
| Jun 06 2019 | INSY | Insys Therapeutics ... | Housley Andrece | Chief Financial Off ... | Grant | A | 0.00 | 3,992 | 0 | 20,994 | 17 K to 21 K (+23.48 %) |
| Jun 05 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Executive Off ... | Option Exercise | A | 4.30 | 72,674 | 312,498 | 72,674 | |
| Jun 05 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Executive Off ... | Grant | A | 0.00 | 12,475 | 0 | 62,075 | 49.6 K to 62.1 K (+25.15 %) |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Motahari Saeed | President & CEO | Option Exercise | A | 3.81 | 282,152 | 1,074,999 | 282,152 | |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Motahari Saeed | President & CEO | Option Exercise | A | 8.06 | 64,000 | 515,840 | 64,000 | |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Motahari Saeed | President & CEO | Grant | A | 0.00 | 59,206 | 0 | 130,192 | 71 K to 130.2 K (+83.41 %) |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Motahari Saeed | President & CEO | Grant | A | 0.00 | 16,000 | 0 | 70,986 | 55 K to 71 K (+29.10 %) |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Option Exercise | A | 3.81 | 173,000 | 659,130 | 173,000 | |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Option Exercise | A | 8.06 | 42,400 | 341,744 | 42,400 | |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Grant | A | 0.00 | 29,000 | 0 | 49,600 | 20.6 K to 49.6 K (+140.78 %) |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Grant | A | 0.00 | 10,600 | 0 | 20,600 | 10 K to 20.6 K (+106.00 %) |
| Apr 23 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 6.36 | 20,935 | 133,147 | 20,935 | |
| Apr 23 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 8.06 | 16,000 | 128,960 | 16,000 | |
| Apr 23 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Grant | A | 0.00 | 8,083 | 0 | 68,166 | 60.1 K to 68.2 K (+13.45 %) |